Testosterone Therapy Monitoring for Women: Blood Tests, Follow-Ups, and Side Effects

Testosterone therapy monitoring for women combines blood tests with a review of symptoms, side effects, and whether treatment is helping. Guidelines commonly recommend checking total testosterone before treatment and again about 3 to 6 weeks after starting, with continued checks once treatment is stable. The purpose is to assess benefit while avoiding excessive exposure, not to reach the highest possible number. [1,2]

If you have just started treatment, it is reasonable to want a clear answer to a simple question: how will we know whether this is working for me?

That answer should be part of your prescription plan. Knowing when to repeat testing, what to record between visits, and whom to contact with concerns makes the next appointment more useful.

What should testosterone treatment be trying to improve?

Long-term safety data remain limited, so monitoring does not eliminate every uncertainty about treatment. [1,3]

The strongest evidence supports testosterone for postmenopausal women with hypoactive sexual desire disorder, or HSDD, after a clinical assessment. HSDD involves low desire that causes personal distress. A low blood testosterone result alone does not establish the diagnosis. Evidence does not support using testosterone as a general treatment for energy, cognition, weight loss, or overall wellness. [2,3]

Before starting, ask your clinician to put the goal in plain language. If the goal is improved sexual desire, what change would feel meaningful to you? Less distress? More interest? A different experience of intimacy?

Writing that down gives you something specific to revisit. Your clinician should explain which concern testosterone is intended to address and how the decision to continue will be made.

Which blood tests are used before treatment?

The ISSWSH guideline recommends baseline total testosterone and sex hormone-binding globulin, or SHBG, along with liver function testing and a fasting lipid profile. Your clinician also reviews your medical history and medications. [1]

Ask for a copy of your baseline results, including units and the laboratory reference ranges. Those details make later results easier to compare. If you are unsure how the measurements differ, read our explanation of total testosterone, free testosterone, and SHBG.

Bring a complete list of prescriptions, supplements, and hormone treatments. Include the product name and formulation, rather than writing only “testosterone” or “HRT.” A photo of the label can help avoid confusion.

When should testosterone levels be checked again?

The follow-up schedule should be agreed with your prescriber. A commonly recommended framework is: [1,2]

• Before starting: document baseline testing and treatment goals.
• About 3 to 6 weeks after starting: repeat total testosterone and review tolerability.
• After a dose change: repeat testing within the interval specified by your clinician; ISSWSH recommends within 6 weeks after an increase.
• Once stable: ISSWSH recommends total testosterone monitoring every 4 to 6 months.

Recommendations and local practice differ. The British Menopause Society also emphasizes ongoing monitoring to keep levels within the female physiological range. [4]

Before a blood draw, ask whether the timing of your last application matters for your particular product. Follow the instructions you receive rather than changing your usual routine to influence the result. Record the application time so your clinician can interpret the sample in context.

What testosterone level should women aim for on treatment?

There is no single blood level that predicts the best symptom response for every woman. Monitoring is intended to avoid concentrations above the physiological premenopausal female range, interpreted using the laboratory and assay involved. A result in range does not establish that treatment is beneficial. [1,2]

This is why the appointment needs both parts of the story: your results and your experience.

A useful update might be: “I have used the prescribed product consistently. My main concern has improved slightly, but I have also noticed new skin changes.” That is more actionable than asking only whether your number has gone up.

Do not increase treatment on your own because you feel no improvement or because someone else reports a higher level. Discuss the result and the plan with your prescriber.

What if testosterone is added to estrogen and progesterone?

If you are already using menopausal hormone therapy, adding testosterone creates another change to document. Your next review should consider the whole regimen rather than treating every new symptom as a testosterone effect. The British Menopause Society considers a testosterone trial reasonable for women already taking HRT who have low libido with no other significant contributing factors, after baseline total testosterone confirms the level is not already at the upper end of the normal female range. [4]

Start with a simple timeline. Record when testosterone began and whether the estrogen or progestogen prescription changed around the same time. Include the exact product names, routes, and schedules. The word “HRT” alone does not tell your clinician what you were using on a particular day.

Imagine that you start testosterone in the same week your estrogen patch changes. Two weeks later you notice a change in sleep and sexual interest. Those observations are worth discussing, but the timing alone cannot establish which medication caused which change. This is a hypothetical example, not a prediction of treatment response.

If your clinician recommends changing one part of the regimen, ask what to keep recording and when the change will be reviewed. Do not stop another prescribed hormone or change several medications yourself to create an experiment. A symptom diary can organize observations; it cannot isolate a drug effect with the certainty of a controlled study.

For the separate question of your estrogen and progestogen regimen, see our guide to discussing whether your HRT dose is right. Testosterone laboratory monitoring still needs its own plan.

Which side effects should you report?

New acne, increased facial or body hair, scalp hair thinning, voice changes, or clitoral changes should be discussed with your clinician. Some androgen-related changes can be lasting. Report changes promptly rather than waiting for the next routine blood test. [2,4]

A simple record can include the date you noticed the change, whether it is progressing, and any recent medication changes. Photographs may help document visible changes if you are comfortable keeping them.

With testosterone gel, application instructions also matter for other people in your household. Product labeling warns about transfer through skin contact and fetal harm from exposure during pregnancy. Ask your prescriber how to prevent transfer and what to do if pregnancy is possible or suspected. [5]

How do you know whether treatment is helping?

Use the treatment goal you agreed on at the start. At each review, consider what has changed, whether the change matters to you, and whether the benefits justify any unwanted effects.

The Global Consensus recommends stopping therapy if there is no benefit by 6 months. The British Menopause Society similarly recommends reassessment and discontinuation when an appropriate trial has not helped. [2,4]

If you feel no better, the next step is a clinical review. Ask whether the original treatment goal, other contributors to symptoms, or the treatment itself need reconsideration. Our guide to testosterone for women during perimenopause provides the broader treatment context for that conversation.

Where does Oova fit into the picture?

Oova tracks urinary LH, E3G, and PdG alongside symptoms. It does not currently measure testosterone or SHBG and cannot replace testosterone bloodwork. Its role is to add context about other reproductive hormone patterns when those patterns are relevant to your clinical questions.

If you already track your cycle or use estrogen and progesterone, you can keep those observations together with treatment dates and laboratory reports. Seeing the sequence can help you explain what changed. It cannot prove that a particular medication caused the change or identify the correct testosterone dose.

‍

Use Oova for the markers it measures, and keep your clinician-directed testosterone testing appointments. A more complete record supports a conversation; it does not turn a urinary reproductive hormone test into a testosterone monitor.

What should you record between appointments?

Choose a short record that you can keep consistently. You do not need to rate every part of your health every day. Begin with the symptom or concern that led to treatment, the prescribed routine, and anything new that you want your clinician to review.

For example, use a simple weekly note about sexual interest and associated distress rather than a general “hormones feel better” score. Keep your own definition of meaningful improvement visible. It is easier to assess a treatment when the goal does not change every time a new result arrives.

Record medication start dates, prescribed changes, missed applications, and the date of blood collection. Bring the actual product label if there is any uncertainty about the formulation. Record unwanted effects when you notice them rather than trying to reconstruct their timing months later.

Also note major changes outside the prescription, such as a new medicine, illness, or a change in sleep or work schedule. These notes do not diagnose the cause of a symptom. They give the clinician enough context to ask a more useful follow-up question.

Three questions to settle at the follow-up visit

Is the intended benefit actually meaningful to me?

Describe the change in the terms you agreed at the beginning. “My interest has improved but the distress has not” is a different update from “I do not notice any benefit.” Either observation can be part of an honest treatment review.

Avoid judging the whole experience by one particularly good or difficult day. Bring the short record you kept and ask your clinician how to assess it over the interval that matters for your plan.

Are the results and unwanted effects being considered together?

Bring the laboratory report with units and reference ranges, not just a number copied into a message. Describe side effects even if you have been told the level is in range. The point of a clinical review is to consider the information together.

A reassuring number should not end a conversation about an unwanted change. Likewise, a number outside the expected range needs the prescriber’s assessment rather than an adjustment copied from someone else’s regimen.

What exactly happens next?

Before leaving, confirm whether the plan is to continue, reassess, change treatment under supervision, or investigate another contributor to the original concern. Ask when repeat bloodwork is due and how you will receive the results.

Write down who to contact between appointments. A follow-up plan is most useful when you know which questions can wait for the scheduled review and which changes should prompt an earlier call.

Frequently asked questions

Do women need blood tests while taking testosterone?

Yes. Testosterone therapy guidelines recommend baseline and repeat blood testing alongside clinical review. Feeling well does not replace checking for excessive exposure. [1,2]

Does a normal testosterone result mean treatment is working?

No. A laboratory result helps assess exposure. Treatment benefit is evaluated against the symptom or concern being treated. [2]

Can Oova monitor my testosterone dose?

No. Oova measures urinary LH, E3G, and PdG, not testosterone. Use clinician-directed blood testing for testosterone monitoring.

Should I increase testosterone if I still have low libido?

Discuss persistent symptoms with your prescriber. Do not change the dose yourself. Low desire needs a broader assessment, and more testosterone is not necessarily the answer. [2,3]

Bring the whole treatment picture into focus

For your next review, gather the product labels, baseline and recent blood tests, medication change dates, and a short description of benefits and unwanted effects. Lead with the question you need answered: “Should I continue this treatment, and what information supports that decision?”

If tracking other reproductive hormone patterns would help organize your experience, explore Oova’s perimenopause tracking. It measures LH, E3G, and PdG alongside symptoms. Continue using blood testing and clinical follow-up for testosterone itself.